Smashed Peaches

Drug Research Studies

Havn Life Sciences to take its magic-mushroom growing firm public this summer – Proactive Investors USA & Canada

Havn Life Sciences Inc Co-CEO Susan Chapelle tells Proactive the privately-held Vancouver-based biotechnology company is looking to take its magic mushroom-focused firm public, expecting to launch its IPO this summer.

Chapelle says what’s more, the firm is progressing with its research in growing psilocybin mushrooms to help fix the restrictive supply-chain issue some firms conducting clinical studies are facing in this space.